SEOUL, South Korea, April 13, 2020 /PRNewswire/ -- VUNO, a member company of the Born2Global Centre, announced that their AI based screening solution for the fundus, VUNO Med®-Fundus AI™ is approved as a Class III medical device by the Ministry of Food and Drug Safety. VUNO Med®-Fundus...
from PR Newswire: https://ift.tt/3emkCha
No comments:
Post a Comment